Literature DB >> 20142114

Predictors of B-type natriuretic peptide and left atrial volume index in patients with preserved left ventricular systolic function: an echocardiographic-catheterization study.

Marie-Perrine Jaubert1, Sébastien Armero, Laurent Bonello, Alexane Nicoud, Pascal Sbragia, Franck Paganelli, Stéphane Arques.   

Abstract

BACKGROUND: B-type natriuretic peptide (BNP) and left atrial volume index (LAVi) are used as surrogate measures for global myocardial function and are recommended for the diagnosis of heart failure with normal ejection fraction. Little is known, however, about predictors in patients with preserved systolic function. AIMS: To identify factors that influence the relation of BNP and left atrial size to invasively determined left ventricular end-diastolic pressure in stable patients with preserved left ventricular systolic function.
METHODS: Fifty-nine consecutive patients were included prospectively. Clinical, biological, Doppler echocardiographic and invasive variables were collected simultaneously.
RESULTS: BNP was predicted independently by left ventricular ejection fraction, diastolic function and age (p<0.05). LAVi was predicted independently by left ventricular mass index and invasive left ventricular end-diastolic pressure (p<0.01). BNP predicted increased left ventricular end-diastolic pressure greater than 16 mmHg (p=0.004); the optimal cut-off value was 33 pg/mL (area under the receiver-operating characteristic curve [AUC] 0.74 [0.6-0.84], p<0.001, sensitivity 72%, specificity 70%). LAVi predicted increased left ventricular end-diastolic pressure (p<0.001); the optimal cut-off value for LAVi was 26 mL/m(2) (AUC 0.87 [0.75-0.94], p<0.001; sensitivity 85%, specificity 80%). Unlike BNP (p=0.1), LAVi performed well in patients with abnormal relaxation at mitral filling (p<0.01).
CONCLUSION: BNP is influenced by age in stable patients with preserved systolic function and should be interpreted cautiously. LAVi is a powerful surrogate for invasively determined left ventricular end-diastolic pressure regardless of age and mitral filling. Copyright 2009 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20142114     DOI: 10.1016/j.acvd.2009.10.005

Source DB:  PubMed          Journal:  Arch Cardiovasc Dis        ISSN: 1875-2128            Impact factor:   2.340


  6 in total

Review 1.  Assessment of left atrial volume: a focus on echocardiographic methods and clinical implications.

Authors:  Chee W Khoo; Suresh Krishnamoorthy; Hoong Sern Lim; Gregory Y H Lip
Journal:  Clin Res Cardiol       Date:  2010-09-07       Impact factor: 5.460

2.  The role of B-type natriuretic peptide in diagnosing acute decompensated heart failure in chronic kidney disease patients.

Authors:  Amer N Kadri; Roop Kaw; Yasser Al-Khadra; Hasan Abuamsha; Keyvan Ravakhah; Adrian V Hernandez; Wai Hong Wilson Tang
Journal:  Arch Med Sci       Date:  2018-08-13       Impact factor: 3.318

Review 3.  Left atrial structure and function in heart failure with reduced (HFrEF) versus preserved ejection fraction (HFpEF): systematic review and meta-analysis.

Authors:  Xuanyi Jin; Jan F Nauta; Chung-Lieh Hung; Wouter Ouwerkerk; Tiew-Hwa Katherine Teng; Adriaan A Voors; Carolyn Sp Lam; Joost P van Melle
Journal:  Heart Fail Rev       Date:  2022-01-26       Impact factor: 4.654

4.  Echocardiographic estimation of left ventricular filling pressures in patients with mitral valve stenosis.

Authors:  Roya Sattarzadeh; Anahita Tavoosi; Parvin Tajik
Journal:  Cardiovasc J Afr       Date:  2014 Jan-Feb       Impact factor: 1.167

5.  Marked elevation of B-type natriuretic peptide in patients with heart failure and preserved ejection fraction.

Authors:  Samuel Tate; Andrea Griem; Blythe Durbin-Johnson; Clifton Watt; Saul Schaefer
Journal:  J Biomed Res       Date:  2014-06-07

Review 6.  Diagnostic Accuracy of Tissue Doppler Index E/e' for Evaluating Left Ventricular Filling Pressure and Diastolic Dysfunction/Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.

Authors:  Oleg F Sharifov; Chun G Schiros; Inmaculada Aban; Thomas S Denney; Himanshu Gupta
Journal:  J Am Heart Assoc       Date:  2016-01-25       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.